Publications of the research groups: september 2011
Pediatrics
Callejón L, Boix C, López Sala A, Colomé R, Fumadó V, Sans A. Perfil neuropsicológico de niños adoptados internacionalmente en Cataluña. An Pediatr (Barc) 2011 :in print. Impact Factor: 0,570.
Carretero JM, Palacios JR, Prada F. Single coronary artery-right ventricular fistula. Cardiol Young 2011 :in print. Impact Factor: 0,858.
Rives S, Camós M, Estella J, Gómez P, López Duarte M, Navajas A, Badell I. Validation of the 'French Acute Lymphoblastic Leukaemia Study Group FRALLE prognostic index' for paediatric Philadelphia-chromosome acute lymphoblastic leukaemia. Br J Haematol 2011 :in print. Impact Factor: 4,942.
Childhood infectious diseases and immunopathology
García MB, Domínguez O, Juan M, Aróstegui JI, Badell I, Chapman E, Martín Mateos MA. Type I leucocyte adhesion deficiency (LAD I). Report of a case. Allergol Immunopathol (Madr) 2011 :in print. Impact Factor: 0,779.
Turon A, Jordan I, Bras C, Soriano A, Muñoz Almagro C. Síndrome hemolítico urémico y colecistitis por neumococo. An Pediatr (Barc) 2011 :in print. Impact Factor: 0,570.
Wittkop L, Günthard HF, De Wolf F, Dunn D, Cozzi A, De Luca A, Kücherer C, Obel N, Von Wyl V, Masquelier B, Stephan C, Torti C, Antinori A, García F, Judd A, Porter K, Thiébaut R, Castro H, Van Sighem AI, Colin C, Kjaer J, Lundgren JD, Paredes R, Pozniak A, Clotet B, Phillips A, Pillay D, Chêne G. EuroCoord-CHAIN Study Group. Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infec Dis 2011 ;11 (5) :363-71. Impact Factor: 16,144.
Adult disease or fetal origin in the early years of life
Bassols J, Prats Puig A, Soriano P, García González MM, Reid J, Martínez Pascual M, Mateos F, De Zegher F, Ibáñez L, López Bermejo A. Lower Free Thyroxin Associates with a Less Favorable Metabolic Phenotype in Healthy Pregnant Women. J Clin Endocrinol Metab 2011 :in print. Impact Factor: 6,495.
Gómez Roig MD, García Algar O. Crecimiento intrauterino restringuido: ¿problema de definición o de contenido? An Pediatr (Barc) 2011 ;75 (3) :157-60. Impact Factor: 0,570.
González Bosquet E, Suñol M, Torralba A, Lozada C, Minano J, Laïlla JM. Hysteroscopic diagnosis of uterine sarcomas at the Department of Gynaecology, Sant Joan de Deu University Hospital. Eur J Gynaecol Oncol 2011 ;32 (4) :399-400. Impact Factor: 0,633.
Prats A, Bassols J, Bargalló E, Mas M, Ribot R, Soriano P, Berengüí A, Díaz M, De Zegher F, Ibáñez L, López Bermejo A. Toward an early marker of metabolic dysfunction: omentin-1 in prepubertal children. Obesity 2011 ;19 (9) :1905-7. Impact Factor: 3,531.
Neuronal development and metabolic diseases
Fickie MR, Lapunzina P, Gentile JK, Tolkoff N, Kroshinsky D, Galan E, Gean E, Martorell L, Romanelli V, Toral JF, Lin AE. Adults with Sotos syndrome: Review of 21 adults with molecularly confirmed NSD1 alterations, including a detailed case report of the oldest person. Am J Med Genet A 2011 ;155 (9) :2105-11. Impact Factor: 2,505.
Morey M, Castro L, Barreiro J, Cabanas P, Pombo M, Gil M, Bernabeu I, Díaz Grande JM, Rey L, Ariceta G, Rica I, Nieto J, Vilalta R, Martorell L, Vila Cots J, Aleixandre F, Fontalba A, Soriano L, García Sagredo JM, García Minaur S, Rodríguez B, Juaristi S, García Pardos C, Martínez Peinado A, Millan JM, Medeira A, Moldovan O, Fernández A, Loidi L. Genetic diagnosis of X-linked dominant hypophosphatemic rickets in a cohort study: Tubular reabsorption of phosphate and 1,25(OH)2D serum levels are associated with PHEX mutation type. BMC Med Genet 2011 ;12 (1) :116. Impact Factor: 2,439.
Pérez Dueñas B, Sempere A, Campistol J, Alonso I, Díez M, González V, Merinero B, Desviat LR, Artuch R. Novel features in the evolution of adenylosuccinate lyase deficiency. Eur J Pediatr Neurol 2011 :in print. Impact Factor: 1,994.
Tondo M, Poo P, Naudó M, Ferrando T, Genovés J, Molero M, Martorell L. Predisposition to epilepsy in fragile X syndrome: Does the Val66Met polymorphism in the BDNF gene play a role? Epilepsy Behav 2011 :in print. Impact Factor: 1,994.
Molecular biology of developing tumors
Acosta S, Mayol G, Rodríguez E, Lavarino C, De Preter K, Kumps C, García I, De Torres C, Mora J. Identification of tumoral glial precursor cells in neuroblastoma. Cancer Lett 2011 :in print. Impact Factor: 4,864.
Health technologies and outcomes in primary care
Gili M, Luciano JV, Bauza N, Aguado J, Serrano MJ, Armengol S, Roca M. Psychometric properties of the IDS-SR30 for the assessment of depressive symptoms in spanish population. BMC Med Res Methodol 2011 ;11 (1) :131. Impact Factor: 2,153.
Rubio Valera M, Fernández A, Luciano JV, Hughes CM, Pinto Meza A, Moreno Küstner B, Palao DJ, Haro JM, Serrano Blanco A. Psychotropic prescribing in primary care in Catalonia--results from an epidemiological study. Fam Pract 2011 :in print. Impact Factor: 1,709.
Research and innovation in surgery
Martínez Vilalta M, Maestre Y, Royo I, Ibáñez Zafón I, Grande L, Parés D. Does correlation exist between anorectal manometry and endoanal ultrasound findings in healthy subjects according to age? Rev Esp Enferm Dig 2011 ;103 (6) :304-9. Impact Factor: 1,130.
Vallverdú H, Comajuncosas J, Orbeal RA, López Negre JL, Gris PJ, Jimeno J, Hermoso J, Sánchez Pradell C, Torra S, Urgellés J, Parés D. Results of implementation of a fast track pathway for diagnosis of colorectal cancer. Rev Esp Enferm Dig 2011 ;103 (8) :402-7. Impact Factor: 1,130.
Pathogenesis and treatment of severe mental disorders
Grzadzinski R, Di Martino A, Brady E, Mairena MA, O'Neale M, Petkova E, Lord C, Castellanos FX. Examining Autistic Traits in Children with ADHD: Does the Autism Spectrum Extend to ADHD? J Autism Dev Disord 2011 ;41 (9):1178-91. Impact Factor: 2,962.
Haro JM, Novick D, Bertsch J, Karagianis J, Dossenbach M, Jones PB. Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) study. Br J Psychiatry 2011 ;199 (3) :194-201. Impact Factor: 5,947.
San L, Rubio G, Bernardo I. Immediate clinical assessment of medical intervention in schizophrenic patients admitted to an acute-care psychiatric unit: a retrospective, naturalistic and multicenter study. Int J Clin Pract 2011 ;15 (3) :196-203. Impact Factor: 0,327.
Sevilla Dedieu C, Kovess V, Gilbert F, Vilagut G, Koenig HH, Bruffaerts R, Haro JM, Alonso J. Mental health care and out-of-pocket expenditures in Europe: results from the ESEMeD project. J Ment Health Policy Econ 2011 ;14 (2) :95-105. Impact Factor: 1,806.
Usall J, Huerta Ramos E, Iniesta R, Cobo J, Araya S, Roca M, Serrano Blanco A, Teba F, Ochoa S. Raloxifene as an adjunctive treatment for postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial. J Clin Psychiatry 2011 :in print. Impact Factor: 5,023.